Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005
NCT ID: NCT01176305
Last Updated: 2010-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Venous Thromboembolism in Pregnancy Study
NCT00856076
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969
Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial
NCT05878899
Evaluation of Pre-dose and Post-dose Anti-factor Xa Levels With Enoxaparin Use During Pregnancy
NCT00319176
Pregnancy and Risk of Venous Thromboembolism
NCT03659708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All Danish Women 15 to 49 years old in the period January 1995 through December 2005, free of previous VTE and current use of oral contraceptives are included.Non-pregnant women are controls.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Danish Women 15 to 49 years old.
Free of previous VTE and current use of oral contraceptives.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Free of previous VTE and current use of oral contraceptives.
Exclusion Criteria
15 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillerod Hospital, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hillerod Hospital, Gynecolocical-Obstetrical department
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RAV1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.